Research Articles
The Cancer Drug Traffic Jam: How a New Model Predicts When Treatments Clash Instead of Collaborate
Discover how IPDsim, an interpretable model, predicts clinical antagonism in cancer combination therapies for personalized treatment.
The Magic Bullet Makeover: How Scientists Are Engineering Smarter Cancer-Targeting Missiles
Discover how scientists are revolutionizing cancer treatment through antibody-drug conjugates (ADCs) and the surprising discovery that weaker antibodies may create better targeted therapies.
Unlocking Nature's Double-Edged Sword: How Ancient Herb Pairing Enhances Cancer Fighting While Taming Toxicity
Discover how Nrf2 activation reduces toxicity and enhances the anti-tumor effect of Radix Tripterygium wilfordii through traditional herbal processing technology.
FAK-Targeting PROTAC: Degrading Cancer's Master Switch
Explore how FAK-targeting PROTAC technology revolutionizes cancer treatment by degrading both enzymatic and scaffolding functions of focal adhesion kinase.
The Trojan Horse: Outsmarting Cancer with Smarter Platinum Drugs
Explore how Pt(IV) prodrugs act as Trojan horses to deliver targeted cancer therapy with reduced side effects compared to traditional chemotherapy.
Breaking the Resistance: How a Novel Fully Human ImmunoRNase is Revolutionizing Cancer Therapy
Explore how fully human immunoRNases are overcoming multidrug resistance in ErbB2-positive cancers through innovative targeted therapy approaches.
Unlocking Cancer Therapy Secrets: How Scientists Supercharged ONTAK Immunotoxin Production
Discover how Iranian researchers optimized culture medium for ONTAK immunotoxin production using recombinant E. coli, potentially revolutionizing cancer treatment.
Taming the Guardian: How Scientists Are Designing Precision Weapons Against Cancer's Survival Protein
Exploring the cutting-edge approaches to design selective peptide inhibitors targeting Bfl-1, a key anti-apoptotic protein in cancer cells.